Lamotrigine vs. phenytoin for treatment of status epilepticus: Comparison in an experimental model

Epilepsy Research

Volumn 24, Issue 1, 1996, Pages 19-28

  Walton, Nancy Y ^a,b   Jaing, Qibo ^a   Hyun, Benjamin ^a   Treiman, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Lamotrigine; Phenytoin; Rat; Status epilepticus

Indexed keywords

LAMOTRIGINE; PHENYTOIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; EPILEPTIC STATE; GRAND MAL SEIZURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TONIC CLONIC SEIZURE;

EID: 0029894429     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-1211(96)00007-1     Document Type: Article

References (25)

1. Altrup, U., Gerlach, G., Reith, H., Said, M.N. and Speckmann, E.-J., Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): I. Antiepileptic actions, Epilepsia, 33 (1992) 743-752.
2. Epilepsy Foundation of America, Treatment of convulsive status epilepticus, J. Am. Med. Assoc., 270 (1993) 854-859.
3. Fazio, A., Artesi, C., Russo, M., Trio, R., Oteri, G. and Pisani, F., A liquid chromatographic assay using a high-speed column for the determination of lamotrigine, a new antiepileptic drug, in human plasma, Ther. Drug Monit., 14 (1992) 509-512.
4. Kapur, J. and Lothman, E.W., NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures, Epilepsy Res., 5 (1991) 103-111.
5. Kapur, J., Stringer, J.L. and Lothman, E.W., Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition, J. Neurophysiol., 61 (1989) 417-426.
6. Leach, M.J., Marden, C.M. and Miller, A.A., Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action, Epilepsia, 21 (1986) 490-497.
7. Litchfield, J.T. and Wilcoxon, F., A simplified method of evaluating dose-effect experiments, J. Pharmacol. Exp. Ther., 96 (1949) 99-113.
8. Loescher, W., Hoenack, D. and Taylor, C.P., Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain, Neurosci. Lett., 128 (1991) 150-154.
9. Macdonald, R.L. and Kelly, K.M., Antiepileptic drug mechanisms of action, Epilepsia, 36 (Suppl. 2) (1995) S2-S12.
10. McLean, M.J., Gabapentin, Epilepsia, 36 (Suppl. 2) (1995) S73-S86.
11. Messenheimer, J.H., Lamotrigine, Epilepsia, 36 (Suppl. 2) (1995) S87-S94.
12. Michelson, H.B., Kapur, J. and Lothman, E.W., Reduction of paired pulse inhibition in the CA1 region of the hippocampus in status epilepticus induced by pilocarpine in naive and in amygdala-kindled rats, Exp. Neurol., 104 (1989) 264-271.
13. Miller, A.A., Wheatley, P.L., Sawyer, D.A., Baxter, M.G. and Roth, B., Pharmacological studies on lamotrigine, a novel potenital antiepileptic drug: I: anticonvulsant profile in mice and rats, Epilepsia, 21 (1986) 483-489.
14. Rowan, A.J., Binnie, C.D., Warfield, C.A., Meinardi, H. and Meijer, J.W.A., The delayed effect of sodium valproate on the photoconvulsive response in man, Epilepsia, 20 (1979) 61-68.
15. Taylor, C.P., Emerging perspectives on the mechanism of action of gabapentin. Neurology, 44 (Suppl. 5) (1994) S10-S16.
16. Treiman, D.M., Meyers, P.D., Walton, N.Y. and the DVA Status Epilepticus Cooperative Study Group, Duration of generalized convulsive status epilepticus (GCSE): relationship to clinical symptomatology and response to treatment, Epilepsia, 33 (Suppl. 3) (1992) 67.
17. Walton, N.Y., Gunawan, S. and Treiman, D.M., Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine, Epilepsy Res., 19 (1994) 237-244.
18. Walton, N.Y. and Treiman, D.M., Experimental secondarily generalized convulsive status epilepticus induced by D,L-homocysteine thiolactone, Epilepsy Res., 2 (1988) 79-86.
19. Walton, N.Y. and Treiman, D.M., Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp. Neurol., 101 (1988) 267-275.
20. Walton, N.Y. and Treiman, D.M., Phenobarbital treatment of status epilepticus in a rodent model, Epilepsy Res., 4 (1989) 216-221.
21. Walton, N.Y. and Treiman, D.M., Efficacy of ACC-9653 (a phenytoin prodrug) in experimental status epilepticus in the rat, Epilepsy Res., 5 (1990) 165-168.
22. Walton, N.Y. and Treiman, D.M., Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice, Neurology, 40 (1990) 990-994.
23. Walton, N.Y. and Treiman, D.M., Vaproic acid treatment of experimental status epilepticus, Epilepsy Res., 12 (1992) 199-205.
24. Walton, N.Y. and Treiman, D.M., Efficacy of a new NMDA receptor antagonist in treatment of experimental status epilepticus, Epilepsia, 34 (Suppl. 6) (1993) 52.
25. Winer, B.J., Statistical Principles in Experimental Design, McGraw-Hill, New York, NY, 1962, 907 pp.